5 Results for "

Acipimox

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Acipimox" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-B0283
CAS No.: 51037-30-0
Synonyms: K-9321
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283A
CAS No.: 76958-97-9
Synonyms: K-9321 sodium
Target:  

Carbonic Anhydrase

Research Areas:  

Metabolic Disease

Acipimox (K-9321) sodium, a nicotinic acid analogue, is an antilipolytic compound. Acipimox sodium stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283R
CAS No.: 51037-30-0
Synonyms: K-9321 (Standard)
Research Areas:  

Metabolic Disease

Acipimox (Standard) is the analytical standard of Acipimox. This product is intended for research and analytical applications. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox stimulates leptin releas, inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283S
CAS No.: 1246816-28-3
Synonyms: K-9321-d4
Acipimox-d4 is the deuterium labeled Acipimox. Acipimox (K-9321), a nicotinic acid analogue, is an antilipolytic compound. Acipimox acutely inhibits lipolysis and suppresses systemic levels of free fatty acids (FFAs) and improves insulin sensitivity .
loading...
    loading...
Cat. No.: HY-B0283S1
CAS No.: 2012598-41-1
Synonyms: K-9321-13C2,15N2
Acipimox- 13C2, 15N2 (K-9321- 13C2, 15N2) is 13C- and 15N-labeled Acipimox (HY-B0283) .
loading...
    loading...